Dose-dependent differential effects of vedolizumab therapy on adhesion of regulatory and effector T cells

Becker E, Wiendl M, Schulz-Kuhnt A, Atreya I, Atreya R, Neurath M, Zundler S (2020)

Publication Type: Conference contribution

Publication year: 2020

Journal

Journal of Crohns & Colitis Elsevier

Publisher: OXFORD UNIV PRESS

City/Town: OXFORD

Pages Range: S165-S166

Conference Proceedings Title: JOURNAL OF CROHNS & COLITIS

DOI: 10.1093/ecco-jcc/jjz203.191

Authors with CRIS profile

Elisabeth Becker Medizinische Fakultät Maximilian Wiendl Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology Anja Schulz-Kuhnt Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology Raja Atreya Professur für Translationale Immunforschung bei chronisch entzündlichen Darmerkrankungen (Heisenberg-Professur) Markus Neurath Lehrstuhl für Innere Medizin I (Medizin 1) Sebastian Zundler Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology

How to cite

APA:

Becker, E., Wiendl, M., Schulz-Kuhnt, A., Atreya, I., Atreya, R., Neurath, M., & Zundler, S. (2020). Dose-dependent differential effects of vedolizumab therapy on adhesion of regulatory and effector T cells. In JOURNAL OF CROHNS & COLITIS (pp. S165-S166). OXFORD: OXFORD UNIV PRESS.

MLA:

Becker, Elisabeth, et al. "Dose-dependent differential effects of vedolizumab therapy on adhesion of regulatory and effector T cells." Proceedings of the JOURNAL OF CROHNS & COLITIS OXFORD: OXFORD UNIV PRESS, 2020. S165-S166.

BibTeX: Download